Foghorn Therapeutics INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Flagship Pioneering and its affiliates increased their beneficial ownership in Foghorn Therapeutics Inc. to 27.2% following a $50 million registered direct offering of common stock and warrants.